Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Hyunah Yoon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA. Hauptthemen laut MEDLINE: Cryptococcus, HIV Infections, Meningitis, Cryptococcal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, NIAID NIH HHS, Einstein-Rockefeller-CUNY Center for AIDS Research, Albert Einstein College of Medicine.
Abstract (Originalsprache)
Background
Asymptomatic cryptococcal antigenemia (positive blood cryptococcal antigen [CrAg]) is associated with increased mortality in individuals with human immunodeficiency virus (HIV) even after adjusting for CD4 count and despite receiving antifungal treatment. The association of antibody immunity with mortality in adults with HIV with cryptococcal antigenemia is unknown.
Methods
Cryptococcal capsular glucuronoxylomannan (GXM)- and naturally occurring β-glucans (laminarin, curdlan)-binding antibodies were measured in blood samples of 197 South Africans with HIV who underwent CrAg screening and were followed up to 6 months. Associations between antibody titers, CrAg status, and all-cause mortality were sought using logistic and Cox regression, respectively.
Results
Compared with CrAg-negative individuals (n = 130), CrAg-positive individuals (n = 67) had significantly higher IgG1 (median, 6672; interquartile range [IQR], 4696–10 414 vs 5343, 3808–7722 μg/mL; P = .007), IgG2 (1467, 813–2607 vs 1036, 519–2012 μg/mL; P = .01), and GXM-IgG (1:170, 61–412 vs 1:117, 47–176; P = .0009) and lower curdlan-IgG (1:47, 11–133 vs 1:93, 40–206; P = .01) titers. GXM-IgG was associated directly with cryptococcal antigenemia adjusted for CD4 count and antiretroviral therapy use (odds ratio, 1.64; 95% confidence interval [CI], 1.21 to 2.22). Among CrAg-positive individuals, GXM-IgG was inversely associated with mortality at 6 months adjusted for CD4 count and tuberculosis (hazard ratio, 0.50; 95% CI, .33 to .77).
Conclusions
The inverse association of GXM-IgG with mortality in CrAg-positive individuals suggests that GXM-IgG titer may have prognostic value in those individuals. Prospective longitudinal studies to investigate this hypothesis and identify mechanisms by which antibody may protect against mortality are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
- Institute for Infection and Immunity, St George's University Hospital NHS Foundation Trust, London, United Kingdom.
- Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
- Clinical Academic Group in Infection and Immunity, St George's University Hospital NHS Foundation Trust, London, United Kingdom.
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
ORCID-Profile: Hyunah Yoon
Förderung
- Medical Research Council
- NIAID NIH HHS
- Einstein-Rockefeller-CUNY Center for AIDS Research, Albert Einstein College of Medicine
- National Center for Advancing Translational Sciences
- Einstein-Montefiore Clinical and Translational Science
- NIH
- Meningitis Research Foundation
- Sir Ratanji Dallal Trust
Zitieren
APA
Yoon, H., Wake, R. M., Nakouzi, A. S., Wang, T., Agalliu, I., Tiemessen, C. T., Govender, N. P., Jarvis, J. N., Harrison, T. S., & Pirofski, L. A. (2023). Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac633
Vancouver
Yoon H, Wake RM, Nakouzi AS, Wang T, Agalliu I, Tiemessen CT, et al. Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac633
BibTeX
@article{Yoon2023,
author = {Yoon, Hyunah and Wake, Rachel M and Nakouzi, Antonio S and Wang, Tao and Agalliu, Ilir and Tiemessen, Caroline T and Govender, Nelesh P and Jarvis, Joseph N and Harrison, Thomas S and Pirofski, Liise-Anne},
title = {Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac633}
}
EUVIMED